Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2025-12-25 @ 10:38 PM
Study NCT ID:
NCT00849667
Status:
TERMINATED
Last Update Posted:
2022-12-30
First Post:
2009-02-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
Sponsor:
Morphotek
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04-16
Start Date Type:
ACTUAL
Primary Completion Date:
2012-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-13
First Submit QC Date:
None
Study First Post Date:
2009-02-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-12-05
Results First Submit QC Date:
None
Results First Post Date:
2022-12-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-07-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-12-05
Last Update Post Date:
2022-12-30
Last Update Post Date Type:
ACTUAL